Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration : A Randomized Phase 2 Trial
dc.contributor.author | Liao, David S | |
dc.contributor.author | Grossi, Federico V | |
dc.contributor.author | El Mehdi, Delphine | |
dc.contributor.author | Gerber, Monica R | |
dc.contributor.author | Brown, David M | |
dc.contributor.author | Heier, Jeffrey S | |
dc.contributor.author | Wykoff, Charles C | |
dc.contributor.author | Singerman, Lawrence J | |
dc.contributor.author | Abraham, Prema | |
dc.contributor.author | Grassmann, Felix | |
dc.contributor.author | Nuernberg, Peter | |
dc.contributor.author | Weber, Bernhard H F | |
dc.contributor.author | Deschatelets, Pascal | |
dc.contributor.author | Kim, Robert Y | |
dc.contributor.author | Chung, Carol Y | |
dc.contributor.author | Ribeiro, Ramiro M | |
dc.contributor.author | Hamdani, Mohamed | |
dc.contributor.author | Rosenfeld, Philip J | |
dc.contributor.author | Boyer, David S | |
dc.contributor.author | Slakter, Jason S | |
dc.contributor.author | Francois, Cedric G | |
dc.date.accessioned | 2020-06-18T18:00:01Z | |
dc.date.available | 2020-06-18T18:00:01Z | |
dc.date.issued | 2020-02 | |
dc.identifier.citation | Liao , D S , Grossi , F V , El Mehdi , D , Gerber , M R , Brown , D M , Heier , J S , Wykoff , C C , Singerman , L J , Abraham , P , Grassmann , F , Nuernberg , P , Weber , B H F , Deschatelets , P , Kim , R Y , Chung , C Y , Ribeiro , R M , Hamdani , M , Rosenfeld , P J , Boyer , D S , Slakter , J S & Francois , C G 2020 , ' Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration : A Randomized Phase 2 Trial ' , Ophthalmology , vol. 127 , no. 2 , pp. 186-195 . https://doi.org/10.1016/j.ophtha.2019.07.011 | en |
dc.identifier.issn | 0161-6420 | |
dc.identifier.other | PURE: 170612802 | |
dc.identifier.other | PURE UUID: 8d77c432-507b-43af-a221-6ef7dbf735df | |
dc.identifier.other | PubMed: 31474439 | |
dc.identifier.other | Scopus: 85071397913 | |
dc.identifier.other | WOS: 000508226400013 | |
dc.identifier.other | ORCID: /0000-0003-1390-7528/work/76211716 | |
dc.identifier.uri | https://hdl.handle.net/2164/14537 | |
dc.description | Copyright © 2019 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved. | en |
dc.format.extent | 10 | |
dc.language.iso | eng | |
dc.relation.ispartof | Ophthalmology | en |
dc.rights | This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Published by Elsevier Inc | en |
dc.subject | ABNORMALITIES | en |
dc.subject | CHOROIDAL NEOVASCULARIZATION | en |
dc.subject | ECULIZUMAB | en |
dc.subject | EYE DISEASE | en |
dc.subject | FEATURES | en |
dc.subject | INFLAMMATION | en |
dc.subject | MACROPHAGE POLARIZATION | en |
dc.subject | PLASTICITY | en |
dc.subject | RANIBIZUMAB TREATMENT | en |
dc.subject | VISION-RELATED FUNCTION | en |
dc.subject | R Medicine | en |
dc.subject | Ophthalmology | en |
dc.subject.lcc | R | en |
dc.title | Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration : A Randomized Phase 2 Trial | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Publisher PDF | en |
dc.identifier.doi | https://doi.org/10.1016/j.ophtha.2019.07.011 | |
dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85071397913&partnerID=8YFLogxK | en |
dc.identifier.vol | 127 | en |
dc.identifier.iss | 2 | en |